PortalPublikationen[Update migraine therapy].

[Update migraine therapy].

Standard

[Update migraine therapy]. / Jürgens, Tim; Tim, P.

in: MMW Fortschr Med, Jahrgang 153, Nr. 14, 14, 2011, S. 49-52.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Jürgens, T & Tim, P 2011, '[Update migraine therapy].', MMW Fortschr Med, Jg. 153, Nr. 14, 14, S. 49-52. <http://www.ncbi.nlm.nih.gov/pubmed/21966870?dopt=Citation>

APA

Jürgens, T., & Tim, P. (2011). [Update migraine therapy]. MMW Fortschr Med, 153(14), 49-52. [14]. http://www.ncbi.nlm.nih.gov/pubmed/21966870?dopt=Citation

Vancouver

Jürgens T, Tim P. [Update migraine therapy]. MMW Fortschr Med. 2011;153(14):49-52. 14.

Bibtex

@article{dcda4d0d5f84425a972589f69ff779f9,
title = "[Update migraine therapy].",
keywords = "Diagnosis, Differential, Humans, Risk Factors, Dose-Response Relationship, Drug, Drug Therapy, Combination, Anti-Inflammatory Agents, Non-Steroidal/adverse effects/therapeutic use, Antiemetics/adverse effects/therapeutic use, Ergotamine/adverse effects/therapeutic use, Migraine Disorders/diagnosis/*drug therapy/etiology/prevention & control, Tryptamines/adverse effects/therapeutic use, Vasoconstrictor Agents/adverse effects/therapeutic use, Diagnosis, Differential, Humans, Risk Factors, Dose-Response Relationship, Drug, Drug Therapy, Combination, Anti-Inflammatory Agents, Non-Steroidal/adverse effects/therapeutic use, Antiemetics/adverse effects/therapeutic use, Ergotamine/adverse effects/therapeutic use, Migraine Disorders/diagnosis/*drug therapy/etiology/prevention & control, Tryptamines/adverse effects/therapeutic use, Vasoconstrictor Agents/adverse effects/therapeutic use",
author = "Tim J{\"u}rgens and P Tim",
year = "2011",
language = "Deutsch",
volume = "153",
pages = "49--52",
journal = "MMW Fortschr Med",
issn = "1438-3276",
publisher = "Urban und Vogel",
number = "14",

}

RIS

TY - JOUR

T1 - [Update migraine therapy].

AU - Jürgens, Tim

AU - Tim, P

PY - 2011

Y1 - 2011

KW - Diagnosis, Differential

KW - Humans

KW - Risk Factors

KW - Dose-Response Relationship, Drug

KW - Drug Therapy, Combination

KW - Anti-Inflammatory Agents, Non-Steroidal/adverse effects/therapeutic use

KW - Antiemetics/adverse effects/therapeutic use

KW - Ergotamine/adverse effects/therapeutic use

KW - Migraine Disorders/diagnosis/drug therapy/etiology/prevention & control

KW - Tryptamines/adverse effects/therapeutic use

KW - Vasoconstrictor Agents/adverse effects/therapeutic use

KW - Diagnosis, Differential

KW - Humans

KW - Risk Factors

KW - Dose-Response Relationship, Drug

KW - Drug Therapy, Combination

KW - Anti-Inflammatory Agents, Non-Steroidal/adverse effects/therapeutic use

KW - Antiemetics/adverse effects/therapeutic use

KW - Ergotamine/adverse effects/therapeutic use

KW - Migraine Disorders/diagnosis/drug therapy/etiology/prevention & control

KW - Tryptamines/adverse effects/therapeutic use

KW - Vasoconstrictor Agents/adverse effects/therapeutic use

M3 - SCORING: Zeitschriftenaufsatz

VL - 153

SP - 49

EP - 52

JO - MMW Fortschr Med

JF - MMW Fortschr Med

SN - 1438-3276

IS - 14

M1 - 14

ER -